Graft-mediated hybridisation of monocotyledonous plants

Patent metadata

Field	Value
Publication number	US-11602107-B2
Application number	US-201917293765-A
Country	US
Kind code	B2
Filing date	Nov 14, 2019
Priority date	Nov 14, 2018
Publication date	Mar 14, 2023
Grant date	Mar 14, 2023

Abstract

The invention relates to the production of graft-mediated hybrid monocotyledonous plants. Methods for the production of such plants are disclosed herein.

First claim

The invention claimed is:

1. A method of producing a hybrid monocot tissue or plant, comprising:
(a) providing a first tissue comprising:
(i) mesocotyl and radicle tissue; or
(ii) mesocotyl and plumule tissue

 of a first monocot plant, wherein said first tissue comprises in its genome a first marker;
(b) providing a second tissue comprising:
(i) mesocotyl and radicle tissue; or
(ii) mesocotyl and plumule tissue

 of a second, different monocot plant, wherein said second tissue comprises in its genome a second, different marker;
(c) placing said first tissue in contact with said second tissue;
(d) allowing fusion of the first and second tissues such that a graft junction forms, wherein said graft junction comprises at least one hybrid cell comprising said first and second markers;
(e) selecting said at least one hybrid cell based on the presence of said first and second markers; and
(f) regenerating a hybrid monocot tissue or plant from said at least one hybrid cell.

2. The method of claim 1 , wherein said first tissue comprises mesocotyl and plumule tissue and said second tissue comprises mesocotyl and radicle tissue.

3. The method of claim 1 , wherein after step (d) and before step (e), said graft junction is cut to provide at least one longitudinal graft junction section, wherein said graft junction section comprises said at least one hybrid cell comprising said first and second markers.

4. The method of claim 1 , wherein said first marker and/or said second marker is a selectable marker, wherein said selectable marker is selectable with a selection agent.

5. The method of claim 1 , wherein said first marker and/or said second marker is a visual marker.

6. The method of claim 1 , wherein said first marker and/or said second marker is an endogenous trait, wherein said endogenous trait is not endogenous to both the first tissue and the second tissue.

7. The method of claim 1 , wherein said first marker and said second marker are selectable markers, wherein said first selectable marker is selectable with a first selection agent and said second selectable marker is selectable with a second, different selection agent.

8. The method of claim 4 , wherein said first selection agent and/or said second selection agent comprises:
(i) an antibiotic;
(ii) a herbicide;
(iii) a toxin;
(iv) salt; or
(v) a sugar.

9. The method of claim 8 , wherein:
(i) said antibiotic is selected from the group consisting of: kanamycin, geneticin (G418), hygromycin, paramomycin, neomycin, spectinomycin, streptomycin, gentamicin, tobramycin, apramycin, bleomycin, phleomycin, streptothricin, and chloramphenicol;
(ii) said herbicide is selected from the group consisting of: glyphosate, glufosinate (or phosphinothricin/BASTA), bialaphos, chlorsulfuron, 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), atrazine, paraquot, methyl viologen, metsulfuron-methyl, triclopyr, 3-Amino-12,4-triazole (3-AT), a sulfonylurea, an imidazolinone, a triazolopyrimidine, a pyrimidinyl oxybenzoate, and a sulfonylamino carbonyl triazolinone;
(iii) said toxin is selected from the group consisting of: 2-deoxyglucose, thialysine, methotrexate, cyanamide, sodium hypochloride, gabaculine, 4-methyl tryptophan, and glycine betaine aldehyde; or
(iv) said sugar is selected from the group consisting of: mannose, xylose and benzyladenine-N-3-glucuronide.

10. The method of claim 7 , wherein said regenerating comprises
placing said graft junction or graft junction section on a base medium comprising at least one auxin, at least one cytokinin and said first and second selection agents such that hybrid tissue forms from said hybrid cell.

11. The method of claim 1 , wherein the first tissue and/or the second tissue are provided:
(i) from a first seed and a second seed; and/or
(ii) by micropropagation in tissue culture.

12. The method of claim 11 , wherein said first seed and/or said second seed comprises its seed coat.

13. The method of claim 11 , wherein said first seed and/or said second seed:
(i) is dry or imbibed in water; and/or
(ii) is partially germinated in the dark.

14. The method of claim 11 , wherein said first seed is imbibed in water and said second seed is dry.

15. The method of claim 11 , wherein:
(i) said first and/or said second seed is transversely cut and/or
(ii) said first and/or said second seed is cut with a tissue puncher.

16. The method of claim 11 , wherein the first tissue and/or the second tissue is tissue cultured on nutrient medium containing a cytokinin.

17. The method of claim 1 , wherein the first tissue and the second tissue are from the same species.

18. The method of claim 1 , wherein the first tissue and the second tissue are from different species within the same order.

19. The method of claim 18 , wherein either one of the first tissue and the second tissue is from a C 3 plant and the other one is from a C 4 plant.

20. The method of claim 18 , wherein either one of the first tissue and the second tissue is:
(i) from a salinity tolerant plant and the other is from a salinity intolerant plant; or
(ii) from a salinity tolerant C 4 plant and the other is from a salinity intolerant C 3 plant.

21. The method of claim 18 , wherein either one of the first tissue and the second tissue is:
(i) from a chilling tolerant plant and the other is from a chilling intolerant plant; or
(ii) from a freezing tolerant plant and the other is from a freezing intolerant plant.

22. The method of claim 18 , wherein either one of the first tissue and the second tissue is:
(i) from a drought tolerant plant and the other is from a drought intolerant plant; or
(ii) from a pathogen resistant plant or pest resistant plant and the other is from a pathogen susceptible plant or pest susceptible plant.

23. The method of claim 18 , wherein at least one trait selected from the group consisting of: perenniality, herbicide resistance, pathogen resistance, insect resistance, mite resistance, nematode resistance, parasitic plant resistance, herbivory resistance, nitrogen fixation, heat tolerance, wind tolerance, heavy metal tolerance, flooding and hypoxic stress tolerance, ozone tolerance, higher yield, lodging resistance, greater facilitation of mechanisation, anti-shattering of pods or seeds, altered plant height and stature, increased biomass, lower utilization of fertilizer, faster life-cycle, higher nutritional content, improved baking, milling and malting quality, improved taste, improved colour and longer shelf-life is conferred to the regenerated hybrid monocot tissue or plant.

24. The method of claim 19 , wherein the C3 plant is bread wheat ( Triticum aestivum ) and the C4 plant is pearl millet ( Pennisetum glaucum ).

Assignees

• Cambridge Entpr Ltd

Inventors

• Reeves Gregory
• Hibberd Julian

Classifications

• A01H1/021

  Methods of breeding using interspecific crosses, i.e. interspecies crosses · CPC title

• A01H1/02 Primary

  Methods or apparatus for hybridisation; Artificial pollination {; Fertility} · CPC title

• A01H6/4636

  Oryza sp. [rice] · CPC title

• A01H6/4684

  Zea mays [maize] · CPC title

• A01H6/4654

  Pennisetum [pearl millet] · CPC title